AC0002

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameAC0002
Drug Alias NameAC0002AC-0002
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTubulin inhibitors
TargetsTubulin
Therapy Area/IndicationsBrain metastasesBrain Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesHangzhou Acea Pharmaceutical Research Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHangzhou Acea Pharmaceutical Research Co Ltd
Inactive CompaniesN/A
Active IndicationsBrain metastasesBrain Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A